Long-Acting Formulations of Insulin

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160228516A1
SERIAL NO

15134152

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SANOFI54 RUE LA BOÉTIE PARIS 75008

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Becker, Reinhard Frankfurt Am Main, DE 115 2973
Boderke, Peter Schwalbach, DE 40 374
Fuerst, Christiane Frankfurt Am Main, DE 12 86
Hahn, Annke Frankfurt Am Main, DE 8 0
Mueller, Werner Frankfurt Am Main, DE 94 841
Werner, Ulrich Frankfurt Am Main, DE 45 447

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation